SynthesisInternational urology and nephrology2026
Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis of stone-free rates and complication profiles.
Synthesis in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy for renal calculi: a grade-assessed meta-analysis of randomized controlled trials with trial sequential analysis.World journal of urology · 2026Pooled it
- F-URS with FANS versus mPCNL for 2-3 cm UUTS: a RCT with a subgroup analysis of 2-2.5 cm stones.BJU international · 2026Trial
- Impact of hydronephrosis grade on surgical parameters and stone-free rates in prone percutaneous nephrolithotomy: a retrospective multivariable study.Open medicine (Warsaw, Poland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNephrolithiasis is a highly prevalent urological condition, necessitating effective and minimally invasive treatment strategies. Percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) are commonly employed for managing renal calculi, but their comparative efficacy and safety remain subjects of ongoing debate. This meta-analysis aims to synthesize current evidence, providing a comprehensive assessment of surgical outcomes between PCNL and RIRS for renal stones under 2 cm and greater than 2 cm, reported across different study designs, various surgical techniques, and different geographical distributions to guide clinical decision-making.
methodsA systematic literature search was conducted across electronic databases, including PubMed, Embase, Scopus, Cochrane, and Clinicaltrials.gov, up to December 2024. Risk of Bias assessment was conducted using the Newcastle-Ottawa Scale for non-randomized cohort studies and the Cochrane Risk of Bias 2.0 (RoB 2.0) tool for RCTs. Data extraction focused on key outcomes such as stone-free rate, complications, operation time, hospital stay, and the need for blood transfusions. Statistical analysis utilized a random-effects model to pool data, with heterogeneity assessed using the I
resultsThe analysis of 62 studies (25 were RCTs and 37 were cohorts) with 7021 patients revealed a significantly higher stone-free rate in the PCNL group compared to RIRS (RR: 1.06, 95% CI [1.04, 1.09], p < 0.00001), indicating greater efficacy in stone clearance. However, PCNL was associated with a significantly higher risk of complications (RR: 1.49, 95% CI [1.25, 1.77], p < 0.00001) and a greater need for blood transfusions (RR: 3.20, 95% CI [1.70, 6.03], p = 0.0003), associated with increased risk. Post-operative hematuria was marginally higher in the PCNL group (RR: 2.06, 95% CI [1.01, 4.19], p = 0.05). Among the PCNL techniques, all PCNL techniques showed significantly higher Hb drop; micro-PCNL was associated with the smallest hemoglobin drop relative to RIRS (MD = 0.62, 95% CI 0.38 to 0.86), followed by mini-PCNL and standard-PCNL. Operation times were comparable between the two procedures, but PCNL resulted in a significantly longer hospital stay (MD: 1.73, 95% CI [1.35, 2.10], p < 0.00001).
conclusionPCNL demonstrates a superior stone-free rate for renal stones under 2 cm and greater than 2 cm, but this is accompanied by a higher risk of complications and a longer hospital stay compared to RIRS. RIRS offers a safer alternative with fewer complications and shorter hospital stays, making it a viable option for at-risk patients. The use of miniaturized PCNL techniques appears to mitigate some of the complication risks associated with traditional PCNL, potentially offering a balance between efficacy and safety. Clinical decision-making should be individualized, considering patient and stone characteristics, surgeon experience, and the availability of advanced PCNL techniques.
Indexed as
Identifiers
40767949What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.